×
DarioHealth Price to Free Cash Flow Ratio 2012-2024 | DRIO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
DarioHealth price to free cash flow ratio from 2012 to 2024. Price to free cash flow ratio can be defined as
View More
DarioHealth Price to Free Cash Flow Ratio 2012-2024 | DRIO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
DarioHealth price to free cash flow ratio from 2012 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$194.7B
Intuitive Surgical (ISRG)
$191.9B
Alcon (ALC)
$42.1B
Edwards Lifesciences (EW)
$41.4B
IQVIA Holdings (IQV)
$34.7B
IDEXX Laboratories (IDXX)
$34.1B
DexCom (DXCM)
$29.2B
STERIS (STE)
$20.9B
Waters (WAT)
$20.5B
SONOVA HOLDING (SONVY)
$20.3B
Hologic (HOLX)
$18.2B
Fresenius Medical Care AG KGaA (FMS)
$13B
Sysmex ADR (SSMXY)
$12.7B
Globus Medical (GMED)
$11.3B
Penumbra (PEN)
$9.1B
Teleflex (TFX)
$9B
Masimo (MASI)
$8.8B
Glaukos (GKOS)
$8B
PROCEPT BioRobotics (PRCT)
$4.9B
Integer Holdings (ITGR)
$4.5B
Veracyte (VCYT)
$3B
Inari Medical (NARI)
$3B
LivaNova (LIVN)
$2.8B
TransMedics (TMDX)
$2.8B
Nihon Kohden (NHNKY)
$2.3B
Elekta AB (EKTAY)
$2.2B
Tandem Diabetes Care (TNDM)
$1.8B
RxSight (RXST)
$1.8B
Integra LifeSciences Holdings (IART)
$1.8B
Alphatec Holdings (ATEC)
$1.4B